Hikma 503B is an FDA-Registered outsourced sterile compounding business focused on providing high quality, ready-to-administer injectable medications that are customized to the specific needs of patients in the United States. Hikma 503B builds on the Hikma group’s expertise and position as a leading supplier of injectable medicines to US hospitals with a strong reputation for quality and reliability. Our goal is to provide our US hospital customers a reliable source of high quality compounded sterile preparations to enable them to meet the needs of their providers and patients.
Company Details
- Employees
- 21
- Founded
- 1978
- Address
- Dayton, New Jersey, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.hikma503B.com
- Keywords
- LLC).
- HQ
- Dayton, New Jersey
Hikma 503b Questions
Hikma 503B's website is https://www.hikma503B.com
Hikma 503B's LinkedIn profile is https://www.linkedin.com/company/hikma-503b
Hikma 503B has
21 employees.
View email and phone details for 21
employees at Hikma 503B.
Hikma 503B's industry is
Pharmaceutical Manufacturing
Hikma 503B's top competitors are
Hikma Pharmaceuticals,
Teva Pharmaceuticals,
Tabuk Pharmaceuticals Manufacturing Company,
Leiters Health,
Ourpharma Llc,
Arab Medical Containers/ Hikma Pharmaceuticals Group,
Quva,
Aurobindo Pharma Usa, Inc.,
Krs Global Biotechnology 503b State-Of-The-Art Facility,
Ms Pharma.
Hikma 503B's categories are Pharmaceutical Manufacturing
Hikma 503B's founding year is 1978
